Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationCell reports methods
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publicationNature aging
View this publicationLeukemia
View this publicationBiomedicines
View this publicationiScience
View this publicationKidney medicine
View this publicationJournal of clinical immunology
View this publicationThe Annals of thoracic surgery
View this publication